Private Advisor Group’s CervoMed CRVO Stock Holding History

Private Advisor Group’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-173	Closed	-$4K	–	3849
2020 Q1	$4K	Buy	173 +26	+18%	+$789	﹤0.01%	1417
2019 Q4	$5K	Buy	+147	New	+$8.98K	﹤0.01%	1621

Other funds holding CRVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

SAMH

Shanda Asset Management Holdings Tortola,, British Virgin Islands $1.85B AUM 36.09% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Private Advisor Group's CRVO Position: Q2 2020 in Review

Private Advisor Group sold out of CervoMed (CRVO) in Q2 2020, closing a stake of 173 shares — an estimated $4K sold.

Private Advisor Group first reported a position in CRVO in Q4 2019 and held it in 2 quarters. The position peaked at $5K in Q4 2019. 22 funds tracked by Wall St. Rank hold CRVO as of Q2 2020.

Private Advisor Group reported no remaining CervoMed position as of Q2 2020 after selling out during the quarter.
Private Advisor Group sold 173 CervoMed shares in Q2 2020, an estimated $4K.
Private Advisor Group first reported a position in CervoMed in Q4 2019 and held it in 2 quarters.
Private Advisor Group's CervoMed position peaked at $5K in Q4 2019.
22 funds tracked by Wall St. Rank held CervoMed as of Q2 2020.

Based on Private Advisor Group's 13F filing for Q2 2020, filed 17 Aug 2020.